发明名称 VERÄNDERTE TNFALPHA-MOLEKÜLE, DNS, WELCHE FÜR DERARTIGE VERÄNDERTE TNFALPHA-MOLEKÜLE KODIERT UND IMPFSTOFFE, DIE DERARTIGE VERÄNDERTE TNFALPHA-MOLEKÜLE UND DNS ENTHALTEN
摘要 A modified human TNFalpha molecule is capable of raising neutralizing antibodies towards unmodified human TNFalpha following administration of the modified TNFalpha to a human host, wherein one or more peptide fragments of the human TNFalpha molecule has been substituted by one or more peptides containing immunodominant T cell epitopes or a truncated form of the molecule containing the immunodominant epitope and one or both flanking regions of the human TNFalpha-molecule containing at least one TNFalpha B cell epitope, wherein the substitution introduces a substantial change in the amino acid sequence of any one of the strands of the front beta-sheet, in any one of the connecting loops, or in any one of the B', I, or D strands of the back beta-sheet.
申请公布号 AT326481(T) 申请公布日期 2006.06.15
申请号 AT19980916866T 申请日期 1998.04.15
申请人 PHARMEXA A/S 发明人 JENSEN, MARTIN, ROLAND;MOURITSEN, SOREN;ELSNER, HENRIK;DALUM, IBEN
分类号 G01N33/53;A61K;A61K31/505;A61K38/00;A61K38/19;A61K38/22;A61K39/00;A61P1/04;A61P3/10;A61P11/06;A61P17/06;A61P19/02;A61P19/10;A61P29/00;A61P35/00;C07K9/00;C07K14/33;C07K14/525;C07K16/24;C07K19/00;C12N;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12N15/11;C12N15/28;C12N15/63;C12P21/02;(IPC1-7):C07K14/525 主分类号 G01N33/53
代理机构 代理人
主权项
地址